ANALYSIS OF INTERNATIONAL REQUIREMENTS FOR DESIGNING OF CLINICAL TRIALS

ANALYSIS OF INTERNATIONAL REQUIREMENTS FOR DESIGNING OF CLINICAL TRIALS

During the analysis of international requirements for designing of clinical trials we found that principal documents are provided by ICH. The main standard in Russian Federation is the National State Standard “Good Clinical Practice”, that is similar to ICH GCP. Thorough industrial standards are iss...

Full description

Saved in:
Bibliographic Details
Main Authors: O. S. Kobyakova, E. S. Kulikov, I. A. Deev, A. A. Dmitriev, N. A. Tabakaev, I. D. Pimenov, D. S. Tyufilin
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:Разработка и регистрация лекарственных средств
Subjects:
clinical trials design
harmonization
regulator y requirements
ich
fda
ema
Online Access:https://www.pharmjournal.ru/jour/article/view/99
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During the analysis of international requirements for designing of clinical trials we found that principal documents are provided by ICH. The main standard in Russian Federation is the National State Standard “Good Clinical Practice”, that is similar to ICH GCP. Thorough industrial standards are issued by global regulators: FDA and EMA. Currently there is absence of local regulatory documents on designing clinical trials in Russia, thus there might be a distinct need in development of national regulatory documents and its harmonization with international standards for pharmaceutical industry.
ISSN:2305-2066
2658-5049

Similar Items